Related Experiment Video
Updated: Jan 11, 2026
Noninvasive Electrocardiography in the Perinatal Mouse
Published on: June 12, 2020
Translating Adult Electrophysiology Technology to Pediatric and Congenital Electrophysiology
Edward O'Leary1, Natasja M S de Groot2
1Division of Electrophysiology, Department of Cardiology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.
Insights
Translating adult electrophysiology therapies to pediatric congenital heart disease (CHD) populations presents unique challenges. This review explores these hurdles and evaluates innovative technologies for pediatric application.
Area of Science:
- Cardiology
- Pediatric Electrophysiology
- Congenital Heart Disease
Background:
- Adult electrophysiology therapies are advancing rapidly.
- Pediatric and congenital heart disease (CHD) populations have unique physiological characteristics.
- Translating adult innovations to pediatrics requires careful consideration.
Purpose of the Study:
- To review the current status of translating adult electrophysiologic therapies to pediatric and CHD patients.
- To identify and analyze the specific challenges in pediatric electrophysiology.
- To assess the potential utility of advanced electrophysiologic technologies in young patients.
Main Methods:
- Literature review of current electrophysiologic therapies and technologies.
- Analysis of challenges specific to pediatric and CHD electrophysiology.
- Evaluation of adult innovations for pediatric applicability.
Main Results:
- Pediatric electrophysiology faces challenges related to patient size, anatomy, and arrhythmia substrate.
- Existing adult technologies may require adaptation for pediatric use.
- Innovative approaches are needed to bridge the gap between adult and pediatric electrophysiology.
Conclusions:
- Successful translation of electrophysiologic therapies requires addressing pediatric-specific challenges.
- Further research and technological adaptation are crucial for advancing pediatric electrophysiology.
- Optimizing treatments for pediatric and CHD patients is essential for improving outcomes.
Abstract:
This review intends to summarize the present landscape of translating electrophysiologic therapies designed for adults to the pediatric and congenital heart disease (CHD) populations. Unique challenges faced by pediatric and congenital electrophysiologists with respect to patient size, cardiac anatomy, and arrhythmia substrate are explored. An analysis of presently relevant key technologies at the forefront of adult electrophysiologic innovation is performed, along with a discussion of their potential utilities in the pediatric and CHD populations.
